Related Experiment Videos
Nitric oxide in septic shock: directions for future therapy?
W M Hon1, H E Khoo, S Moochhala
1Department of Medicine, National University of Singapore.
Abstract:
Septic shock is a major cause of death among patients in intensive care units. It has a mortality rate of 20% to 80%. The clinical syndrome of septic shock is characterised by hypotension, hyporesponsiveness to vasoconstrictors and volume depletion which will then lead to multiorgan dysfunction and death. Except for surgical and supportive care, no specific therapy is known. Recently interest has been focused on the role of nitric oxide (NO) in septic shock. Large amounts of NO released by the endothelium and vascular smooth muscle cells lead to profound vasodilation and hyporesponsiveness to vasoconstrictors. The cytotoxic effect of NO could also cause tissue injury and organ failure. Inhibition of NO synthase, the enzyme responsible for NO production, has been proposed as a new therapy for septic shock. However, experimental reports have provided conflicting results, demonstrating both beneficial and detrimental effects. A brief review of the role of NO in septic shock and the possible use of NO synthase inhibitors as potential therapeutic agents is presented here.
Insights
Nitric oxide (NO) plays a key role in septic shock, causing vasodilation and organ damage. Inhibiting NO synthase may offer a new therapy, but research shows mixed results for this septic shock treatment.
Area of Science:
- Critical Care Medicine
- Physiology
- Pharmacology
Background:
- Septic shock is a leading cause of death in intensive care units, characterized by hypotension and multi-organ dysfunction.
- Current treatments for septic shock are limited to surgical and supportive care, with no specific therapies available.
- Nitric oxide (NO) is increasingly recognized for its significant role in the pathophysiology of septic shock.
Purpose of the Study:
- To review the role of nitric oxide (NO) in the development of septic shock.
- To explore the potential of inhibiting NO synthase as a therapeutic strategy for septic shock.
- To summarize conflicting experimental findings on NO synthase inhibitors in septic shock models.
Main Methods:
- Literature review of experimental studies on nitric oxide and septic shock.
- Analysis of the mechanisms by which NO contributes to septic shock.
- Evaluation of studies investigating NO synthase inhibitors in septic shock.
Main Results:
- Elevated NO levels contribute to vasodilation and hyporesponsiveness to vasoconstrictors in septic shock.
- NO may exert cytotoxic effects, leading to tissue injury and organ failure.
- Experimental data on NO synthase inhibitors in septic shock show both beneficial and detrimental outcomes.
Conclusions:
- Nitric oxide (NO) is a critical mediator in septic shock, contributing to its hallmark features.
- Inhibition of NO synthase presents a potential therapeutic avenue, but requires further investigation due to conflicting results.
- Understanding NO's complex role is essential for developing effective treatments for septic shock.